EPISODE · Apr 6, 2026 · 6 MIN
今天3分钟我们来聊聊国内首个异体γδ-T细胞临床启动
from 源于细胞BioInsid的个人播客
2026年3月30日，国内首个异体γδ-T细胞注射液I期临床在广州启动，为晚期肝癌等实体瘤患者带来新希望。该疗法无需配型，攻克传统CAR-T难题，安全性高，对实体瘤效果显著。前往小宇宙评论区与主播互动
Embed this episode
Ready to play
今天3分钟我们来聊聊国内首个异体γδ-T细胞临床启动
0:00
6:22
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 源于细胞BioInsid的个人播客?
This episode is 6 minutes long.
When was this 源于细胞BioInsid的个人播客 episode published?
This episode was published on April 6, 2026.
Can I download this 源于细胞BioInsid的个人播客 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!